Innate Pharma【IPH】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.708

買値

1.70

売値

1.73

出来高

38,761

1.702 日の範囲 1.728

1.332 52 週間の範囲 2.79

時価総額

543.435M

前日終値

1.712

始値

1.724

時刻

1.708

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

155,823

発行済株式数

318,170,508

配当利回り

PER

-71.85

1 株当たり利益 (EPS)

-0.02

歳入

61.64M

純利益

-7.57M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.innate-pharma.com

本社

Marseille, Bouches-du-rhone, Fra

設立

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker IPH. The last closing price for Innate Pharma was 1.71 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.79 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 544.71 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -71.85.

Innate Pharma annonce l’organisation d’une conférence destinée aux analystes et investisseurs pour présenter sa stratégie dans le domaine des conjugués anticorps-médicaments

Innate Pharma présentera IPH4502, son programme conjugué anticorps-médicament (ADC) le plus avancé au stade clinique Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) («...

Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 31 décembre 2024

Regulatory News: Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (Euronext Paris : IPH...

Innate Pharma annonce une stratégie de transformation pour accélérer sa croissance

Une stratégie axée sur le développement clinique précoce de molécules propriétaires présentant un potentiel en monothérapie : Stimuler l’innovation grâce à la plateforme ANKET® produisant des «...

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P...

Innate Pharma présente à l’ASH 2024 des données de l’étude de Phase 2 TELLOMAK sur l’amélioration de la qualité de vie chez des patients atteints de lymphomes T cutanés

Les résultats mettent en évidence des signes précoces prometteurs selon lesquels lacutamab pourrait aider à soulager certains des symptômes les plus éprouvants des lymphomes T cutanés...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.04	-2.28832951945	1.748	1.77	1.702	53594	1.72695964	DE
4	-0.242	-12.4102564103	1.95	2.02	1.702	86033	1.81660124	DE
12	-0.002	-0.116959064327	1.71	2.49	1.332	155823	1.76632345	DE
26	-0.402	-19.0521327014	2.11	2.49	1.332	95607	1.81654785	DE
52	-0.812	-32.2222222222	2.52	2.79	1.332	82117	2.0269895	DE
156	-2.006	-54.0118470652	3.714	3.8	1.332	132508	2.63229041	DE
260	-5.002	-74.5454545455	6.71	8.3	1.332	267662	3.99506906	DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?

The current share price of Innate Pharma is 1.708 €

How many Innate Pharma shares are in issue?

Innate Pharma has 318,170,508 shares in issue

What is the market cap of Innate Pharma?

The market capitalisation of Innate Pharma is EUR 544.71M

What is the 1 year trading range for Innate Pharma share price?

Innate Pharma has traded in the range of 1.332 € to 2.79 € during the past year

What is the PE ratio of Innate Pharma?

The price to earnings ratio of Innate Pharma is -71.85

What is the cash to sales ratio of Innate Pharma?

The cash to sales ratio of Innate Pharma is 8.83

What is the reporting currency for Innate Pharma?

Innate Pharma reports financial results in EUR

What is the latest annual turnover for Innate Pharma?

The latest annual turnover of Innate Pharma is EUR 61.64M

What is the latest annual profit for Innate Pharma?

The latest annual profit of Innate Pharma is EUR -7.57M

What is the registered address of Innate Pharma?

The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma website address?

The website address for Innate Pharma is www.innate-pharma.com

Which industry sector does Innate Pharma operate in?

Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MLCOTCoretech 5	0.021 € (61.54%)	102.18k
AELISAelis Farma SA	3.36 € (46.09%)	24.42k
ALIMOGroupimo	0.182 € (43.31%)	484
ALCWECharwood Energy SA	3.14 € (36.52%)	10.6k
FPGUnion Tech Info	0.268 € (26.42%)	11.65k
DMSBSDiagnostic Medical Systems	0.0045 € (-35.71%)	818
ALTROTronic s Microsystems	3.90 € (-28.44%)	23
ALNMRNamR SA	0.344 € (-28.33%)	90.71k
GNROGeNeuro SA	0.1625 € (-27.46%)	1.06M
ALOKWGroupe Okwind SA	3.30 € (-20.29%)	35.38k
ATOAtos SE	0.0021 € (0.00%)	1.18B
BCPBanco Comercial Portugues SA	0.5154 € (-0.62%)	61.83M
ALCYBCybergun	0.0001 € (0.00%)	56.47M
ALVERVergnet	0.0014 € (0.00%)	19.39M
EDPEDP SA	2.901 € (-0.65%)	13.72M